Mouse interleukin-20 receptor 1a targets renal epithelial cells and is associated with renal calcium deposition

Genes and Immunity

Volumn 10, Issue 3, 2009, Pages 237-247

  Wei, Chi Chen ^a,b   Chang, Ming Shi ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTERLEUKIN 20 RECEPTOR 1A; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME RELEASE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY EPITHELIUM; MOUSE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RNA SPLICING; UPREGULATION;

ANIMALS; APOPTOSIS; CALCIUM OXALATE; CELL LINE; CHEMOKINE CCL2; CHEMOKINE CCL5; EPITHELIAL CELLS; INTERLEUKIN-6; KIDNEY TUBULES, COLLECTING; KIDNEY TUBULES, PROXIMAL; L-LACTATE DEHYDROGENASE; MICE; MICE, TRANSGENIC; NEPHROLITHIASIS; REACTIVE OXYGEN SPECIES; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS;

EID: 67349140903     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.93     Document Type: Article

References (54)

1. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1: 442-450.
2. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S et al Interleukin 20: Discovery, receptor identification, and role in epidermal function. Cell 2001; 104: 9-19.
3. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144-10149.
4. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
5. Knappe A, Hor S, Wittmann S, Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 2000; 74: 3881-3887.
6. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002; 277: 47517-47523.
7. Hsing CH, Hsieh MY, Chen WY, Cheung So E, Cheng BC, Chang MS. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 2006; 81: 2196-2201.
8. Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 2005; 153: 911-918.
9. Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, Chen WC et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005; 153: 591-595.
10. Hsieh MY, Chen WY, Jiang MJ, Cheng BC, Huang TY, Chang MS. Interleukin-20 promotes angiogenesis in a direct and indirect manner. Genes Immun 2006; 7: 234-242.
11. Hsing CH, Ho CL, Chang LY, Lee YL, Chuang SS, Chang MS. Tissue microarray analysis of interleukin-20 expression. Cytokine 2006; 35: 44-52.
12. Hsu YH, Li HH, Hsieh MY, Liu MF, Huang KY, Chin LS et al. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum 2006; 54: 2722-2733.
13. Caligiuri G, Kaveri SV, Nicoletti A. IL-20 and atherosclerosis: Another brick in the wall. Arterioscler Thromb Vasc Biol 2006; 26: 1929-1930.
14. Chen WY, Cheng BC, Jiang MJ, Hsieh MY, Chang MS. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 2090-2095.
15. Wei CC, Hsu YH, Li HH, Wang YC, Hsieh MY, Chen WY et al. IL-20: biological functions and clinical implications. J Biomed Sci 2006; 13: 601-612.
16. Wei CC, Chen WY, Chen PJ, Lee YJ, Wang DH, Chen WC et al. Detection of IL-20 and its receptors on psoriasis skin. Clin Immunol 2005; 117: 65-72.
17. Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W et al. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther 2006; 13: 1011-1022.
18. Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y et al. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther 2006; 13: 753-761.
19. Chen WY, Cheng YT, Lei HY, Chang CP,Wang CW, Chang MS. IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun 2005; 6: 493-499.
20. Saito Y, Miyahara R, Gopalan B, Litvak A, Inoue S, Shanker M et al Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene. Cancer Gene Ther 2005; 12: 238-247.
21. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R et al mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2003; 2: 347-353.
22. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K et al. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA 2002; 99: 10054-10059.
23. Wei CC, Chang MS. A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis. Genes Immun 2008; 9: 668-679.
24. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: 26-32.
25. Lieske JC, Deganello S. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol 1999; 10 (Suppl 14): S422-S429.
26. Khan SR, Hackett RL. Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 1991; 5: 707-711; discussion 711-702.
27. Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA et al. Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 1999; 10 (Suppl 14): S457-S463.
28. Khan SR. Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 2004; 8: 75-88.
29. Byer K, Khan SR. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 2005; 173: 640-646.
30. Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23: 71-79.
31. Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron 2004; 98: E55-e60.
32. Koul HK. Role of p38 MAP kinase signal transduction in apoptosis and survival of renal epithelial cells. Ann NY Acad Sci 2003; 1010 62-65.
33. Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Menon M, Koul HK. Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 2002; 277: 13321-13330.
34. Knoll T, Steidler A, Trojan L, Sagi S, Schaaf A, Yard B et al. The influence of oxalate on renal epithelial and interstitial cells. Urol Res 2004; 32: 304-309.
35. Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T et al. Oxalate toxicity in LLC-PK1 cells: Role of free radicals. Kidney Int 1996; 49: 413-419.
36. Kaneto H, Fukuzaki A, Ishidoya S, Takeda A, Ogata Y, Sasaki T et al mRNA expression of chemokines in rat kidneys with ureteral obstruction. Nippon Hinyokika Gakkai zasshi 2000; 91: 69-74.
37. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176.
38. Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 2002; 61: 105-112.
39. Dickman KG, Jacobs WR, Mandel LJ. Renal metabolism and acute renal failure. Pediatr Nephrol 1987; 1: 359-366.
40. Burke TJ, Burnier M, Langberg H, Shanley P, Schrier RW. Renal response to shock. Ann Emerg Med 1986; 15: 1397-1400.
41. Andreoli SP. The pathophysiology of the hemolytic uremic syndrome. Curr Opin Nephrol Hypertens 1999; 8: 459-464.
42. Sarica K, Erbagci A, Yagci F, Bakir K, Erturhan S, Ucak R. Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. Urol Res 2004; 32: 271-277.
43. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001; 281: F948-F957.
44. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288: F1069-F1077.
45. Kuin A, Kruse JJ, Stewart FA. Proteinuria and vascular changes after renal irradiation: The role of reactive oxygen species (ROS) and vascular endothelial growth factor (Vegf). Radiat Res 2003; 159 174-181.
46. Yamamoto T, Nagase M, Hishida A, Honda N. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: Comparison with those in IgA nephropathy. Lupus 1993; 2: 261-268.
47. Kelly KJ. Acute renal failure: Much more than a kidney disease. Semin Nephrol 2006; 26: 105-113.
48. Evevquoz D, Rosman J, Reichenstein T, Garzoni D, Rohrer W, Thiel G. C-reactive protein and early diagnosis of kidney transplant rejection. Schweiz Med Wochenschr 1993; 123: 1837-1842.
49. Ernest S, Bello-Reuss E. Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol 1995; 269 (2 Part 1): C323-C333.
50. Wei CC, Li HH, Hsu YH, Hsing CH, Sung JM, Chang MS. Interleukin-20 targets renal cells and is associated with chronic kidney disease. Biochem Biophys Res Commun 2008; 374: 448-453.
51. Pizzolato P. Histochemical recognition of calcium oxalate. J Histochem Cytochem 1964; 12: 333-336.
52. Liegler TJ, Hyun W, Yen TS, Stites DP. Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow cytometry. Clin Diagn Lab Immunol 1995; 2: 369-376.
53. Campos AH, Schor N. Mechanisms involved in calcium oxalate endocytosis by Madin-Darby canine kidney cells. Braz J Med Biol Res 2000; 33: 111-118.
54. Wei CC, Chen WY, Wang YC, Chen PJ, Lee JY, Wong TW et al. Detection of IL-20 and its receptors on psoriatic skin. Clin Immunol 2005; 117: 65-72.